Promising Epigenetic Biomarkers for the Early Detection of Colorectal Cancer: A Systematic Review
Open Access
Abstract
In CRC, screening compliance is decreased due to the experienced discomfort associated with colonoscopy, although this method is the gold standard in terms of sensitivity and specificity. Promoter DNA methylation (hypomethylation or hypermethylation) has been linked to all CRC stages. Study objectives: to systematically review the current knowledge on approved biomarkers, reveal new potential ones, and inspect tactics that can improve performance. This research was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines; the risk of bias was evaluated using the revised Quality Assessment of Diagnostic Accuracy Studies criteria (QUADAS-2). The Web of Science® Core Collection, MEDLINE® and Scopus® databases were searched for original articles published in peer-reviewed journals with the specific keywords “colorectal cancer”, “early detection”, “early-stage colorectal cancer”, “epigenetics”, “biomarkers”, “DNA methylation biomarkers”, “stool or blood or tissue or biopsy”, “NDRG4”, “BMP3”, “SEPT9”, and “SDC2”. Based on eligibility criteria, 74 articles were accepted for analysis. mSDC2 and mSEPT9 were frequently assessed in studies, alone or together as part of the ColoDefense panel test—the latter with the greatest performance. mBMP3 may not be an appropriate marker for detecting CRC. A panel of five methylated binding sites of the CTCF gene holds the promise for early-stage specific detection of CRC. CRC screening compliance and accuracy can be enhanced by employing a stool mt-DNA methylation test.Keywords
This publication has 119 references indexed in Scilit:
- Colorectal cancerNature Reviews Disease Primers, 2015
- Epigenetic Alterations in Colorectal Cancer: Emerging BiomarkersGastroenterology, 2015
- Aging of blood can be tracked by DNA methylation changes at just three CpG sitesGenome Biology, 2014
- DNA methylation age of human tissues and cell typesGenome Biology, 2013
- A comparative overview of general risk factors associated with the incidence of colorectal cancerTumor Biology, 2013
- Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal CancerThe Journal of Molecular Diagnostics, 2013
- Genome-wide Methylation Profiles Reveal Quantitative Views of Human Aging RatesMolecular Cell, 2013
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Differential colorectal carcinogenesis: Molecular basis and clinical relevanceWorld Journal of Gastrointestinal Oncology, 2010
- Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance CharacteristicsJNCI: Journal of the National Cancer Institute, 2007